Skip to content
Vibativ(telavancin)
Vibativ (telavancin) is a small molecule pharmaceutical. Telavancin was first approved as Vibativ on 2009-09-11. It is used to treat bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, and streptococcal infections in the USA. It has been approved in Europe to treat bacterial pneumonia and cross infection.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Vibativ
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Telavancin hydrochloride
Tradename
Company
Number
Date
Products
VIBATIVCumberland PharmaceuticalsN-022110 RX2009-09-11
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
vibativNew Drug Application2021-01-01
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infectionsD001424A49
infectious skin diseasesD012874
pneumoniaEFO_0003106D011014J18
staphylococcal infectionsD013203A49.01
streptococcal infectionsEFO_1001476D013290
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Telavancin Hydrochloride, Vibativ, Cumberland Pharms
75316232027-01-01DP
66356182023-09-11DS, DPU-728
ATC Codes
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01X: Other antibacterials in atc
J01XA: Glycopeptide antibacterials
J01XA03: Telavancin
HCPCS
Code
Description
J3095
Injection, telavancin, 10 mg
Clinical
Clinical Trials
25 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248HP_0002019K59.013227
GastroparesisD018589EFO_1000948K31.8411
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DyspepsiaD004415EFO_0008533K3066
Irritable bowel syndromeD043183EFO_0000555K58112
Opioid-induced constipationD00007968922
Gastroesophageal refluxD005764EFO_0003948K2122
HeartburnD006356R1211
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic diseaseD00290811
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTELAVANCIN
INNtelavancin
Description
Telavancin is a glycopeptide that is vancomycin substituted at position N-3'' by a 2-(decylamino)ethyl group and at position C-29 by a (phosphonomethyl)aminomethyl group. Used as its hydrochloride salt for treatment of adults with complicated skin and skin structure infections caused by bacteria. It has a role as an antibacterial drug and an antimicrobial agent. It is functionally related to a vancomycin.
Classification
Small molecule
Drug classvancomycin-related compounds
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O
Identifiers
PDB
CAS-ID372151-71-8
RxCUI473837
ChEMBL IDCHEMBL507870
ChEBI ID71229
PubChem CID3081362
DrugBankDB06402
UNII IDXK134822Z0 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Vibativ - Cumberland Pharmaceuticals
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Vibativ - Innoviva, Inc.
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,501 documents
View more details
Safety
Black-box Warning
Black-box warning for: Vibativ
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
4,568 adverse events reported
View more details